DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has commenced a project with the University of Cambridge’s Innovation Centre in Digital Molecular Technologies (iDMT), an open innovation research centre co-funded by the University of Cambridge, AstraZeneca, Shionogi, and the European Regional Development Fund. DeepMatter will provide its DigitalGlassware® platform to iDMT as part of the […]

Created to provide early-warning and education of digital biosecurity threats Founding members include BioBright, with Charles Fracchia joining BIO-ISAC Board of Directors Inaugural event on 8th August 2021 at DEF-CON Boston, US: Dotmatics, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, […]

HELSINKI, Finland —  Finnish bioinformatics software company Euformatics has been awarded funding through the Amazon Web Services (AWS) Diagnostic Development Initiative to deliver a revolutionary COVID-19 variant surveillance software tool. SYNLAB has agreed to be the first customer of the solution developed under the program. The funding also covers broader deployment of cloud-based tools around human […]

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process Basel, Switzerland and Framingham, MA, USA—July 29, 2021—Genedata, leading provider of biopharma enterprise software solutions, and SCIEX, a global leader in life science analytical technologies, have entered into a strategic partnership to develop new […]

HOUSTON–(BUSINESS WIRE)–Jul. 26, 2021– Kiromic Biopharma, Inc. (Nasdaq: KRBP), a pioneer in immuno oncology cellular therapy in solid tumors, is pleased to announce it has completed the acquisition of InSilico Solutions. InSilico Solutions is a world-class bio-informatics and artificial intelligence innovator with a long standing collaborative relationship with its clients at MD Anderson Cancer Center, Johns Hopkins School of […]

Burlingame, California — Collaborative Drug Discovery, Inc. (CDD), provider of the web-based drug discovery informatics platform CDD Vault, announces the launch of a new data offering named BioHarmony. BioHarmony provides semantically curated live feeds of drug data from diverse sources. Often researchers may focus too narrowly on one aspect of a problem, however by culling data […]

Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that its genomic interpretation software is now CE marked under the In Vitro Diagnostics Directive (98/79/EC). With the In Vitro Diagnostic (IVD) designation, Congenica’s clinical decision support platform can make the transition […]

New 20/15 Visioneers and Eagle Genomics Partnership to Promote Global Microbiome Education and Standardization New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights. Hereford, Pennsylvania, USA & Cambridge, UK - Today, 20/15 Visioneers LLC. (20/15), a […]

New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and   Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights.  Hereford, Pennsylvania, USA & Cambridge, UK – Today, 20/15 Visioneers LLC. (20/15), a leading computational and scientific informatics management consulting and marketing company, and Eagle Genomics Ltd. (Eagle), a leading global microbiome data and analytics company, announced a new partnership, focused on raising awareness of improved microbiome […]

Cambridge, UK – 21 July 2021 – Cresset, innovative provider of outstanding software for molecule discovery and design, is pleased to announce that OncoArendi Therapeutics SA (WSE: OAT), a biotechnology company which specializes in the discovery and development of new drugs, has licensed Flare™ for use in its internal development programs. Cresset software uses its proprietary descriptors of […]